We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out about the long-term effects some people can have after having COVID-19.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
There have been a small number of reports of serious and life-threatening anticholinergic side effects associated with hyoscine hydrobromide patches, particularly when used outside the licence. Healthcare professionals, patients, parents and carers should be aware of the signs and symptoms...
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Latest data from the UK Health Security Agency (UKHSA) on scarlet fever and invasive group A streptococcus cases.
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg. Results from a placebo-controlled study in children younger than 12 years with acute gastroenteritis did not show any difference in...
The symptoms, diagnosis, management, surveillance and epidemiology of salmonella.
The characteristics, symptoms, diagnosis and epidemiology of chikungunya.
Provides guiding principles on how planning can deal with land affected by contamination.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.